Beyond the Itch: Chronic Kidney Disease-associated Pruritus, a Multimodal Approach, and the Role of Difelikefalin
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Rayner H, Larkina M, Wang M, Graham-Brown M, van der Veer S, Ecder T
. International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis. Clin J Am Soc Nephrol. 2017; 12(12):2000-2007.
PMC: 5718267.
DOI: 10.2215/CJN.03280317.
View
2.
Kimata N, Fuller D, Saito A, Akizawa T, Fukuhara S, Pisoni R
. Pruritus in hemodialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study (JDOPPS). Hemodial Int. 2014; 18(3):657-67.
DOI: 10.1111/hdi.12158.
View
3.
Verduzco H, Shirazian S
. CKD-Associated Pruritus: New Insights Into Diagnosis, Pathogenesis, and Management. Kidney Int Rep. 2020; 5(9):1387-1402.
PMC: 7486142.
DOI: 10.1016/j.ekir.2020.04.027.
View
4.
Topf J, Wooldridge T, McCafferty K, Schomig M, Csiky B, Zwiech R
. Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies. Kidney Med. 2022; 4(8):100512.
PMC: 9396406.
DOI: 10.1016/j.xkme.2022.100512.
View
5.
Stander S, Fishbane S, Schaufler T, Ruessmann D, Morin I, Menzaghi F
. Chronic kidney disease-associated pruritus and quality of life with difelikefalin treatment: a analysis of phase 3 data using the Skindex-10 questionnaire. Clin Kidney J. 2024; 17(10):sfae274.
PMC: 11484513.
DOI: 10.1093/ckj/sfae274.
View